The largest database of trusted experimental protocols

3 protocols using evis lucera elite cv 290

1

Magnifying Endoscopic Examination of the Pharynx

Check if the same lab product or an alternative is used in the 5 most similar protocols
All endoscopic procedures were carried out using a magnifying endoscope (GIF-H260Z; Olympus Medical Systems, Tokyo, Japan) with a hood attachment (MAJ-1990; Olympus Medical Systems). The videoendoscopy system used in this study comprised a video processor (EVIS LUCERA ELITE CV-290; Olympus Medical Systems) and a light source (EVIS LUCERA ELITE CLV-290SL; Olympus Medical Systems). Prior to the procedure, each patient was given 100 mL water containing 20,000 units pronase (Kaken Pharmaceutical, Tokyo, Japan), 1 g sodium bicarbonate, and 10 mL dimethylpolysiloxane (20 mg/mL; Horii Pharmaceutical Industries, Osaka, Japan).
Afterward, pharyngeal anesthesia was performed as described in “Study design and anesthesia protocols.”
Patients were placed in the left lateral decubitus position, with endoscopic examinations carried out while they were awake or under conscious sedation with midazolam (Dormicum Injection; Astellas Pharma, Tokyo, Japan). The patient's wish to the use of a sedative was obtained before the procedure. The sedative was adjusted within the range of 2 mg to 5 mg based on the patient's body weight. The pharynx was assessed at the beginning of each examination, and standard endoscopy was carried out at the end of each pharyngeal examination. If pharyngeal lesions were detected, the examination was completed first and the lesions were evaluated at the end of endoscopy.
+ Open protocol
+ Expand
2

Diagnostic Capability of DCSS for Early Gastric Lesions

Check if the same lab product or an alternative is used in the 5 most similar protocols
We sought to assess the diagnostic capability of the DCSS using white light, non-magnified images by retrospectively analyzing of our database. This system uses only white light, non-magnified images. We enrolled 855 cases who underwent EGD and were diagnosed with early gastric carcinoma (EGC) or malignant lymphoma (ML) at Chiba University Hospital and Chiba Foundation for Health Promotion and Disease Prevention from September 2014 to January 2019. For GC, we included only cases in the early stage that were considered eligible for endoscopic treatment, and excluded cases in the advanced stage that were eligible for surgery or chemotherapy. Multiple endoscopists captured the endoscopic images using standard endoscopes [GIF-H260, GIF-XP260NS, GIF-H260Z, GIF-Q260J, GIF-H290, GIF-HQ290, GIF-H290Z, GIF-H290T, GIF-XP290N (Olympus Corporation, Tokyo, Japan], EG-580NW, EG-590WR, and EG-L600ZW7 (Fujifilm, Tokyo)] and standard video processors [EVIS LUCERA CV-260, CV-260SL, EVIS LUC-ERA ELITE CV-290 (Olympus), Advancia VP-4450, VP-4450HD, and LASEREO VP-7000 (Fujifilm)].
+ Open protocol
+ Expand
3

Analyzing Serrated Lesions with AFI

Check if the same lab product or an alternative is used in the 5 most similar protocols
W E RETROSPECTIVELY REVIEWED data for 48 consecutive patients with 87 serrated lesions that were examined using updated AFI systems (EVIS LUCERA ELITE CLV-290SL, EVIS LUCERA ELITE CV-290, CF-FH260AZI; Olympus Medical Systems, Tokyo, Japan) and resected by endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) at Jikei University Hospital. Traditional serrated adenomas were excluded.
Three regions of interest (ROI) were randomly selected on the AFI image of each serrated lesion, and color intensity analyses for the three ROI were conducted by an endoscopist who was blinded to the pathological assessment results. Then, the mean green/red (G/R) ratio, which is obtained by dividing the mean green color intensities of the three ROI by the mean red color intensities of the three ROI, was calculated for each serrated lesion. Histological assessments to classify the serrated lesions were conducted based on the World Health Organization classification. 12 We compared the mean G/R ratios of each type of serrated lesion.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!